L47, L49- Hypersensitivity, Immune Tolerance, Autoimmunity Flashcards
Type I hypersensitivity reactions have (1) as the immune reactant and Ag in the (2) form. (1)-(2) complex binds to (3) on (4) cells inducing (5).
1- IgE 2- soluble 3- FcεRI 4- mast cells (basophils, eosinophils) 5- degranulation of mast cells
Type II hypersensitivity reactions have (1) as the immune reactant and Ag in the (2) form. (1) binds to (3) leading to (4) activation and (5) of target cell.
1- IgG or IgM 2- cell-bound 3- cellular Ag 4- complement (classical pathway) 5- lysis (Note- IgG can lead to ADCC w/ Tc / NK cells, macrophages, neutrophils)
Type III hypersensitivity reactions have (1) as the immune reactant and Ag in the (2) form. (1)-(2) complexes are deposited in tissues which activates (3) resulting in (4) and recruitment of (5) which will cause local tissue damage.
1- IgG & IgM 2- soluble (SERUM) 3- complement 4- inflammation (C3a, C5a) 5- neutrophils (release enzymes => tissue damage)
Type IV hypersensitivity reactions have (1) as the immune reactant and Ag in the (2) form. (1) secretes (3) to activate (4) cells.
1- T cells (Th1)
2- soluble or cell-bound
3- CKs
4- macrophages & Tc cells
hypersensitivities take place in response to… (hint- 3 things)
- infection that can’t be cleared
- normally harmless exogenous substance (allergen)
- auto-antigen
define hypersensitivity
exaggerated or inappropriate immune response => tissue damage
Type _ hypersensitivity(ies) is(are) Ab mediated (humoral)
Type _ hypersensitivity(ies) is(are) cell mediated
I, II, III –> Ab mediated
IV –> cell mediated
(T/F) hypersensitivities occur upon first contact with Ag
F- never, sensitization occurs on 1st contact, hypersensitivity always upon re-exposure
define atopy
genetic predisposition to produce IgE in response to many common, naturally occuring Ag/allergens (~20% individuals in US)
IgE is the usual response against (1), where it binds (2) after binding Ag on (3) cells
1- metazoal parasites (too large to be phagocytized)
2- FcεRI (high-affinity)
3- mast cells, basophils (+ eosinophils)
Type I hypersensitivities are (immediate/delayed) reactions
immediate-type hypersensitivity
describe development of IgE against (harmless) Ags in upon first contact
- IgM on B cell binds Ag
- Th2 cell binds B cell via CD4 and releases IL-4 / IL-13
- ILs stimulate class switching to IgE
- results in memory B cell + plasma cell producing Allergen specific IgE
list the primary mediators in mast cell granules
(made before and stored)
histamine, proteases, eosinophil chemotactic factor, heparin
list the secondary mediators in mast cells
(2-4 hrs after immediate response)
platelet-activating factor, LTs, PGs, bradykinins, some CKs + chemokines
compare atopic to immune allergy response
(based on genetic + environmental factors)
-Atopic: Th2, IgE; not exposed to pathogens regularly (urban enviro., western diet, widespread Antibiotic use)
-Immune: Th1, IgG, exposed to pathogens regularly (hygiene hypothesis)
examples of localized and systemic Type I hypersensitivity
Local: allergic rhinitis, asthma, food allergies, wheals, atopic eczema
Systemic: anaphylaxis
explains desensitization using Abs
- for type I hypersensitivity in people with mild to moderate allergies (not for extreme- must have some tolerance)
- development of IgG as ‘blocking Abs’ preventing IgE binding and rxn with mast cell
Type II hypersensitivity can involve cytotoxic process where (1) is activated, phagocytosis occurs via (2) receptor, and (3) occurs via NK cells and eosinophils. Non-cytotoxic process involves (4).
1- classical complement pathway (IgG, IgM)
2- FcR and complement receptors
3- ADCC (Ab-dep. cellular cytotoxicity)
4- interference with receptors (anti-receptor Abs)
Autoimmune hemlytic anemia (HDNB) is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type II (cytotoxic)
2- RBC membrane proteins (Rh, ABO)
3- opsonization, phagocytosis, complement-mediated destruction of RBCs
4- hemolysis, anemia
Acute rheumatic fever is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type II (cytotoxic)
2- streptococcal cell-wall Ag (cross-reaction with myocardial Ag)
3- inflammation + macrophage activation
4- myocarditis, arthritis
Goodpasture syndrome is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type II (cytotoxic)
2- type IV collagen (BM of kidney glomeruli + lung alveoli)
3- complement + Fc-receptor-mediated inflammation (IgG accumulation in tissue)
4- nephritis, lung hemorrhage, linear Ab deposits
Myasthenia Gravis is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type II (non-cytotoxic)
2- AChR
3- blocks ACh binding
4- muscle weakness, paralysis
Graves disease is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations)
1- type II (non-cytotoxic)
2- TSH receptor
3- stimulates TSH receptor
4- hyperthyroidism (followed by hypothyroidism)
describe Erythroblastosis fetalis
- Rh+ fetus, Rh- mother
- upon 1st vaginal birth, mother exposed to Rh –> develops IgG against
- upon 2nd pregnancy –> IgGs can cross placenta and damage fetus
- RhoGAM administered to block Rh from being exposed to mother
describe Arthrus reaction
(type III hypersensitivity)
- individual sensitized to Ag
- Ag administered locally (SQ, ID)
- rxn occurs locally
- mast cell mediated
what is serum sickness
(type III hypersensitivity)
- response to foreign protein after receiving anti-serum, which is usually from another animal containing anti-toxin
- deposition of serum immune complex (Ag-IgG/IgM) systemically
- fever, vasculitis, arthitis, nephritis
Type IV hypersensitivities are (immediate/delayed) reactions
delayed-type hypersensitivity (48-72 hrs after second exposure)
Type I hypersensitivities are important for the clearance of…
- intracellular pathogens (ex. M. tuberculosis, Leishmania major)
- if Ag persists –> lytic products of macrophages can damage healthy tissue
describe sensitization phase of Type IV hypersensitivity
upon first exposure, APCs (macrophages, Langerhans cells) present Ag to naive T cells generating Th1 (generally)
describe effector phase of Type IV hypersensitivity
- Th1 cells secrete CKs and chemokines to effect macrophages
- macrophages inc MHC-II, TNF receptors, O2 radicals + NO
prolonged DTH can lead to formation of….
(delayed-type hypersensitivity)
granuloma (surrounding resistant intracellular microbe)
define central tolerance
- deleting T or B clones before maturity if they have receptors that recognize self-Ags with great affinity
- ‘negative selection’
- occurs in primary lymphoid tissues
define peripheral tolerance
- killing lymphocytes that bind self-Ag (high dose) in secondary lymphoid tissue
- regulated by apoptosis or anergy (no proliferation)
(T/F) B cells can escape anergy or deletion in peripheral tolerance
T- Receptor Editing can occur; further rearrangement of their immunoglobulin genes
in peripheral tolerance (1) cells may be responsible for controlling this process, as they recognize (2) and then will (3)
1- Treg cells (CD4+)
2- self-Ag (intermediate affinity)
3- suppress T cells (non-reg) that bind with low affinity to self-Ag
list the 5 ways immunogens can become tolerogens
- high doses of Ag
- persistent Ag
- IV / oral introduction
- absent adjuvants
- low levels of co-stimulators: CD28/B7 low => CTLA-4 binding B7 to inhibit
(T/F) CD28 has higher affinity for B7 than CTLA-4
F- CTLA-4 (inhibitory) has higher affinity than CD28 (activator)
tolerogens induce ______ in mature lymphocytes
apoptosis or anergy
how does the body prevent autoimmunity
- central tolerance
- peripheral tolerance
- immune regulation (Treg cells)
list the immunologically privileged sites and what occurs there (include the CK that might be most responsible)
- brain, eyes, testis, placenta (only exposed to immune system in trauma)
- T cells enter => undergo apoptosis
- foreign Ags (+ tissue grafts) don’t elicit immune responses
- tolerance»_space; destructive reponse
- TGF-β may be key CK responsible
list the 4 ways peripheral tolerance prevents autoimmunity
- lack of co-stimulatory
- lack of Ag presentation
- negative feedback prevents overstimulation
- T cells entering immune-privileged sites undergo apoptosis
list the 6 discussed causes of autoimmunity
- Tolerance => thymic breakdown (genetic) OR in periphery (enviroment)
- HLA (human leukocyte Ag) = genetic predisposition
- release of sequestered Ags (tissue traumas)
- Infection => mimicry of self-Ags (short-lived and reversible)
- some viruses activate B cells non-specifically
- inappropriate MHC expression
(T/F) autoimmune diseases affect women more than men
T
which hypersensitivity mechanisms can result in autoimmunity
- Type II, Ab mediates, immediate rxn
- Type III, immune complex mediated
- Type IV, cell-mediated, delayed rxn
Autoimmune thrombocytopenia purpura is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading
1- type II (cytotoxic)
2- platelets’ integrin or glycoprotein
3- Abs destroy platelets => thrombocytopenia
list the 3 autoimmune anemias (include Ags and through what hypersensitivity mechanism)
[type II cytotoxic mechanism]
- hemolytic anemia: Abs for Rh or AB(O) RBCs
- drug induced anemia
- pernicious anemia: Ab against intestinal protein responsible for B12 uptake
Pernicious anemia is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type II (cytotoxic)
2- intestinal B12 protein responsible for uptake
3- no B12 absorption from intestine
4- anemia (+ neurological symptoms)
systemic autoimmunities are usually due to type ___ hypersensitivity mechanisms
type III (immune complex mediated)
Systemic Lupus Erythematous is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type III
2- antinuclear Ags (ANA): dsDNA (mainly), histones, platelets, leukocytes, clotting factors
3- excessive complement activation (systemically)
4- fever, weakness, arthritis, rash, kidney issues
(note typically affects middle aged women most)
what is an ANA and how is it detected
- antinuclear Ag: dsDNA, histone, ect.
- detected via indirect immunoflorescent Ags
Polymyositis is considered a type (1) hypersensitivity. It involves (2) as target Ag.
1- type IV
2- muscle cells
Hasimoto’s Thyroiditis is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type IV
2- thyroid Ags- mainly TPO (thyroid peroxidase)
3- destruction of thyroid tissue + accumulation of incomplete thyroid hormone
4- hypothyroidism, goiter
(mainly affects middle aged women)
Insulin dependent DM (type I) is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type IV
2- β-cell (pancreas) elements
3- Abs / T cells destroy insulin producing β-cells
4- diabetes
Multiple sclerosis is considered a type (1) hypersensitivity. It involves (2) as a mechanism leading to (3) as clinical manifestations.
1- type IV
2- inflammatory lesions in myelin sheath caused by T cells
3- numbness, paralysis, vision loss
Rheumatoid arthritis is considered a type (1) hypersensitivity. It involves (2) Ag, has (3) as a mechanism leading to (4) as clinical manifestations.
1- type IV
2- Fc region of IgG
3- immune complexes (T cells + IgG) depositing systemically in tissue
4- chronic inflammation of joints
CTLA-4 is expressed on (1) cells in (2) fashion and (3) cells in (4) fashion. CTLA-4 binds to (5). Variants of CTLA-4 has been associated with the following autoimmune diseases: (6).
1/2- Treg cells, constitutively
3/4- activated T cells, only when activated
5- B7-1/CD80, B7-2/CD86
6- type I DM, Grave’s, Hashimoto’s. Celiac’s, SLE, others